Lesage Anne
5 of 20 shown
The 5 most recent of 20 visible filings, newest first.
- Pharvaris N.V. Chief Early Development$765,466Open-market sale
- Pharvaris N.V. Chief Early Development8,000 sharesOption exercise
- Pharvaris N.V. Chief Early Development$1,149,084Open-market sale
- Pharvaris N.V. Chief Early Development$241,500Option exercise
- Pharvaris N.V. Chief Early Development2,972 sharesOption exercise